In this report, we present a new case of mosaic trisomy 13 with prolonged survival, firstly detected by array-CGH analysis which was carried out because of moderate intellectual disability with postaxial hexadactyly, dermatologic features, ventricular septal defect, bicuspid aortic valve, and aortic dystrophy in a 19-year-old male patient. In a subset of 15% of the cells, the patient carried a derivative chromosome 10 generated by a nonreciprocal (10;13) translocation inherited from his healthy mother who carried the translocation in a balanced and homogeneous state. FISH analyses showed interstitial telomeric sequences at the breakpoints. To our knowledge, this is the second report of a patient with trisomy 13 mosaicism displaying a severe aortic root dilatation. We also discuss the mechanisms which could explain the mosaic state, the most likely one being related to the instability of the interstitial telomere.

Keywords:
Bicuspid aortic valve, Interstitial telomere, Mosaicism, Translocation, Trisomy 13
1.
Aypar E, Yildirim MS, Sert A, Ciftci I, Odabas D: A girl with metopic synostosis and trisomy 13 mosaicism: case report and review of the literature. Am J Med Genet A 155A:638-641 (2011).
2.
Campens L, Demulier L, De Groote K, Vandekerckhove K, De Wolf D, et al: Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. Am J Cardiol 114:914-920 (2014).
3.
Devereux RB, de Simone G, Arnett DK, Best LG, Boerwinkle E, et al: Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. Am J Cardiol 110:1189-1194 (2012).
4.
Fortin F, Beaulieu Bergeron M, Fetni R, Lemieux N: Frequency of chromosome healing and interstitial telomeres in 40 cases of constitutional abnormalities. Cytogenet Genome Res 125:176-185 (2009).
5.
Gautier M, Detaint D, Fermanian C, Aegerter P, Delorme G, et al: Nomograms for aortic root diameters in children using two-dimensional echocardiography. Am J Cardiol 105:888-894 (2010).
6.
Ghawi H, Engelhardt K, Dixon K, Thankaval P, Ramaciotti C, et al: Sinus of Valsalva aneurysm in a patient with mosaic trisomy 13. World J Pediatr Congenit Heart Surg (2016), E-pub ahead of print.
7.
González-del Angel A, Estandia-Ortega B, Gaviño-Vergara A, Sáez-de-Ocariz M, Velasco-Hernández Mde L, Salas-Labadía C: A patient with trisomy 13 mosaicism with an unusual skin pigmentary pattern and prolonged survival. Pediatr Dermatol 31:580-583 (2014).
8.
Griffith CB, Vance GH, Weaver DD: Phenotypic variability in trisomy 13 mosaicism: two new patients and literature review. Am J Med Genet A 149A:1346-1358 (2009).
9.
Hinton RB, Martin LJ, Rame-Gowda S, Tabangin ME, Cripe LH, Benson DW: Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve. J Am Coll Cardiol 53:1065-1071 (2009).
10.
Iliopoulos D, Sekerli E, Vassiliou G, Sidiropoulou V, Topalidis A, et al: Patau syndrome with a long survival (146 months): a clinical report and review of literature. Am J. Med Genet A 140:92-93 (2006).
11.
Kasai F, Takahashi E, Koyama K, Terao K, Suto Y, et al: Comparative FISH mapping of the ancestral fusion point of human chromosome 2. Chromosome Res 8:727-735 (2000).
12.
Lévy J, Receveur A, Jedraszak G, Chantot-Bastaraud S, Renaldo F, et al: Involvement of interstitial telomeric sequences in two new cases of mosaicism for autosomal structural rearrangements. Am J Med Genet A 167A:428-433 (2015).
13.
Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, et al: The revised Ghent nosology for the Marfan syndrome. J Med Genet 47:476-485 (2010).
14.
Louvrier C, Egea G, Labalme A, Des Portes V, Gazzo S, et al: Characterization of a de novo supernumerary neocentric ring chromosome derived from chromosome 7. Cytogenet Genome Res 147:111-117 (2015).
15.
Martin LJ, Ramachandran V, Cripe LH, Hinton RB, Andelfinger G, et al: Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations. Hum Genet 121:275-284 (2007).
16.
Meyer RE, Liu G, Gilboa SM, Ethen MK, Aylsworth AS, et al: Survival of children with trisomy 13 and trisomy 18: a multi-state population-based study. Am J Med Genet A 170A:825-837 (2016).
17.
Park VM, Gustashaw KM, Wathen TM: The presence of interstitial telomeric sequences in constitutional chromosome abnormalities. Am J Hum Genet 50:914-923 (1992).
18.
Peroos S, Forsythe E, Pugh JH, Arthur-Farraj P, Hodes D: Longevity and Patau syndrome: what determines survival? BMJ Case Rep2012:bcr0620114381 (2012).
19.
Pylyp L, Zukin V, Mykytenko D, Spinenko L: A rare non-Robertsonian translocation with chromosome fusion der(5;15)(q35.3;q10): segregation analysis in male meiosis and preimplantation embryos. Cytogenet Genome Res 142:161-166 (2014).
20.
Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM: Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 111:777-784 (2003).
21.
Roman MJ, Devereux RB, Kramer-Fox R, OʼLoughlin J: Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 64:507-512 (1989).
22.
Romana SP, Le Coniat M, Berger R: t(12;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 9:186-191 (1994).
23.
Wieser I, Wohlmuth C, Rittinger O, Fischer T, Wertaschnigg D: Cutaneous manifestations in trisomy 13 mosaicism: a rare case and review of the literature. Am J Med Genet A 167A:2294-2299 (2015).
24.
Yeşilyurt A, Dilli D, Oguz S, Dilmen U, Altug N, Candemir Z: Partial trisomy 8p (8p11.2→pTER) and deletion of 13q (13q32→qTER): case report. Genet Couns Geneva Switz 22:35-40 (2011).
© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.